Search

everythinglearnresearchcommunity

for

Search:↓

A patch with curcumin-zinc can improve hair growth and health by delivering beneficial particles to the skin, increasing hair follicles, and reversing effects of a hair loss hormone.

A new method using Platelet-rich Plasma (PRP) in a microneedle can promote hair regrowth more efficiently and is painless, minimally invasive, and affordable.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Mutations in certain receptors can cause diseases and offer new treatment options.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Eating selenium-rich rice improved antioxidant activity and signs of aging in mice.

N6-methyladenosine affects hair follicle development differently in Rex and Hycole rabbits.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.